Jubilant Biosys Ltd, a subsidiary of the Jubilant Pharmova group, operates across Asia and North America, with its R&D centers located in India. The company partners with leading global healthcare organizations, delivering end-to-end drug discovery and contract research services—from target discovery through to candidate selection—using flexible engagement models like Fee-for-Service (FFS), Full-Time Equivalent (FTE), and risk-sharing agreements.
As a contract research, development, and manufacturing organization (CRDMO) based in India, Jubilant Biosys plays a pivotal role in advancing drug discovery by partnering with prominent biotech and pharmaceutical companies worldwide.
Recognized as one of the top preclinical contract research providers, Jubilant Biosys specializes in therapeutic areas such as pain, inflammation, CNS disorders, metabolic diseases, and cancer. The company has developed strong expertise in discovery informatics, computational and medicinal chemistry, structural biology, in vitro and in vivo studies, and translational science.
Headquartered in Bengaluru, India, Jubilant Biosys has become a fully integrated research services provider, combining its scientific excellence with robust clinical development and manufacturing capabilities from other entities within the Jubilant group.
